Cover Image
市場調查報告書

Clearside BioMedical, Inc.:產品平台分析

Clearside BioMedical, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 321955
出版日期 內容資訊 英文 29 Pages
訂單完成後即時交付
價格
Back to Top
Clearside BioMedical, Inc.:產品平台分析 Clearside BioMedical, Inc. - Product Pipeline Review - 2015
出版日期: 2015年12月09日 內容資訊: 英文 29 Pages
簡介

Clearside BioMedical, Inc. 是研究開發並商品化眼睛慢性疾病、會導致失明的疾病之治療藥的生物製藥公司。該公司同時也在開發眼睛內部的最低侵襲性的治療方法。

本報告提供Clearside BioMedical, Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Clearside BioMedical, Inc.的基本資料

Clearside BioMedical, Inc.概要

  • 主要資訊
  • 企業資料

Clearside BioMedical, Inc.: R&D 概要

  • 主要的治療範圍

Clearside BioMedical, Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 聯合治療模式

Clearside BioMedical, Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段的開發中產品
  • IND/CTA 被申請了的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Clearside BioMedical, Inc.:藥物簡介

  • (triamcinolone acetonide + aflibercept)
  • triamcinolone acetonide
  • Small Molecules to Inhibit VEGF and PDGF for Wet AMD
  • Small Molecules to Inhibit VEGF for Wet AMD

Clearside BioMedical, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Clearside BioMedical, Inc.:最近的開發平台趨勢

Clearside BioMedical, Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07853CDB

Summary

Global Markets Direct's, 'Clearside BioMedical, Inc. - Product Pipeline Review - 2015', provides an overview of the Clearside BioMedical, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Clearside BioMedical, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Clearside BioMedical, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Clearside BioMedical, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Clearside BioMedical, Inc.'s pipeline products

Reasons to buy

  • Evaluate Clearside BioMedical, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Clearside BioMedical, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Clearside BioMedical, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Clearside BioMedical, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Clearside BioMedical, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Clearside BioMedical, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Clearside BioMedical, Inc. Snapshot
    • Clearside BioMedical, Inc. Overview
    • Key Information
    • Key Facts
  • Clearside BioMedical, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Clearside BioMedical, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
  • Clearside BioMedical, Inc. - Pipeline Products Glance
    • Clearside BioMedical, Inc. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Clearside BioMedical, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Clearside BioMedical, Inc. - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
  • Clearside BioMedical, Inc. - Drug Profiles
    • triamcinolone acetonide
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • (triamcinolone acetonide + aflibercept)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit VEGF and PDGF for Wet AMD
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit VEGF for Wet AMD
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Clearside BioMedical, Inc. - Pipeline Analysis
    • Clearside BioMedical, Inc. - Pipeline Products by Target
    • Clearside BioMedical, Inc. - Pipeline Products by Route of Administration
    • Clearside BioMedical, Inc. - Pipeline Products by Molecule Type
    • Clearside BioMedical, Inc. - Pipeline Products by Mechanism of Action
  • Clearside BioMedical, Inc. - Recent Pipeline Updates
  • Clearside BioMedical, Inc. - Dormant Projects
  • Clearside BioMedical, Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Clearside BioMedical, Inc., Key Information
  • Clearside BioMedical, Inc., Key Facts
  • Clearside BioMedical, Inc. - Pipeline by Indication, 2015
  • Clearside BioMedical, Inc. - Pipeline by Stage of Development, 2015
  • Clearside BioMedical, Inc. - Monotherapy Products in Pipeline, 2015
  • Clearside BioMedical, Inc. - Combination Treatment Modalities in Pipeline, 2015
  • Clearside BioMedical, Inc. - Phase III, 2015
  • Clearside BioMedical, Inc. - Phase II, 2015
  • Clearside BioMedical, Inc. - Discovery, 2015
  • Clearside BioMedical, Inc. - Pipeline by Target, 2015
  • Clearside BioMedical, Inc. - Pipeline by Route of Administration, 2015
  • Clearside BioMedical, Inc. - Pipeline by Molecule Type, 2015
  • Clearside BioMedical, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Clearside BioMedical, Inc. - Recent Pipeline Updates, 2015
  • Clearside BioMedical, Inc. - Dormant Developmental Projects,2015
  • Clearside BioMedical, Inc., Other Locations

List of Figures

  • Clearside BioMedical, Inc. - Pipeline by Top 10 Indication, 2015
  • Clearside BioMedical, Inc. - Pipeline by Stage of Development, 2015
  • Clearside BioMedical, Inc. - Monotherapy Products in Pipeline, 2015
  • Clearside BioMedical, Inc. - Pipeline by Top 10 Target, 2015
  • Clearside BioMedical, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Clearside BioMedical, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Clearside BioMedical, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top